EnteroMedics, Inc.

Sector: Measuring And Controlling Devices Not Elsewhere Classified Region: MN, United States

Exchange/Ticker: Nasdaq: ETRM

Company Description

EnteroMedics, Inc. is a clinical development stage medical device company with approvals to commercially launch its product in Australia and the European Economic Area. It also designs and develops devices that use neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders. The company's proprietary neuroblocking technology is designed to intermittently block the vagus nerve using high frequency, low energy, electrical impulses. Its initial product under development is the Maestro System, which delivers VBLOC therapy. The VBLOC therapy limits the expansion of the stomach, helps control hunger sensations between meals, reduces the frequency and intensity of stomach contractions and produces a feeling of early and prolonged fullness. The company's current available surgical obesity treatments include gastric bypass surgery and laparoscopic banding alter normal anatomy used to reduce stomach size. It was founded by Mark Knudson, Robert Nickoloff, Timothy Conrad, Katherine Tweden & Rich Wilson on December 19, 2002 and is headquartered in St. Paul, MN.

Similar to: Consilium AB

Featured Company

Fidelity China Special Situations Plc

Surrey, SU, GB

Fidelity China Special Situations Plc is an investment trust with the interest in investments in equities, index linked, equity linked,… Learn more →